Cancer Research UK & Michelle Mitchell

Cancer Research UK: The Cancer Research UK funded the study, demonstrating its commitment to cancer prevention and research, and highlighting the success of public health initiatives.

Michelle Mitchell: As the chief executive of Cancer Research UK, Michelle Mitchell highlighted the vaccine's effectiveness and warned about falling vaccination rates, urging targeted action from the United Kingdom Government.

Cancer Research UK: The charity expresses concern over low uptake and calls for more action.

Michelle Mitchell: Chief Executive of Cancer Research UK, she expresses concern over low uptake.

Michelle Mitchell: Michelle Mitchell, chief executive of Cancer Research UK, called for urgent action and investment in staff and equipment to meet cancer wait time targets, noting that the United Kingdom — National Health Service is not on track.

Michelle Mitchell: Michelle Mitchell, chief executive of Cancer Research UK, expressed concern over rising melanoma cases and emphasized the importance of sun safety and early detection. Her statements reinforce the charity's public health message.